• 1
    Jain R.. Barriers to drug delivery in solid tumors. Sci Am 1994; 271: 5865.
  • 2
    Gerlowski LE, Jain RK. Microvascular permeability of normal and neoplastic tissues. Microvascular Res 1986; 31: 288305.
  • 3
    Heuser LS, Miller FN. Differential macromolecular leakage from the vasculature of tumors. Cancer 1986; 57: 461464.
  • 4
    Schwickert HC, Stiskal M, Roberts TP, et al. Contrast-enhanced MR imaging assessment of tumor capillary permeability: effect of irradiation on delivery of chemotherapy. Radiology 1996; 198: 893898.
  • 5
    Daldrup H, Shames DM, Wendland M, et al. Correlation of dynamic contrast-enhanced MR imaging with histologic tumor grade: comparison of macromolecular and small-molecular contrast media. AJR Am J Roentgenol 1998; 171: 941949.
  • 6
    Brasch RC, Shames DM, Cohen FM, et al. Quantification of capillary permeability to macromolecular magnetic resonance imaging contrast media in experimental mammary adenocarcinomas. Invest Radiol 1994; 29(Suppl 2): S8S11.
  • 7
    Su MY, Wang Z, Carpenter PM, Lao X, Mühler A, Nalcioglu O. Characterization of N-ethyl-N-nitrosurea-induced malignant and benign breast tumors in rats by using three MR contrast agents. J Magn Reson Imaging 1999; 9: 177186.
  • 8
    Jain RK. Physiological barriers to delivery of monoclonal antibodies and other macromolecules in tumors. Cancer Res 1990; 50(Suppl 3): 814819.
  • 9
    Helbich T, Roberts TPL, Rollins MD, et al. 1999. Non-invasive assessment of wound healing angiogenesis with contrast enhanced MRI. Woodstock, Vermont: Contrast Media Research; p 324.
  • 10
    van Dijke CF, Kirk BA, Peterfy CG, Genant HK, Brasch RC, Kapila S. Arthritic temporomandibular joint: correlation of macromolecular contrast-enhanced MR imaging parameters and histopathologic findings. Radiology 1997; 204: 825832.
  • 11
    Demsar F, Van Dijke CF, Kirk BA, et al. Mapping abnormal synovial vascular permeability in temporomandibular joint arthritis in the rabbit using MRI. Br J Rheumatol 1996; 35(Suppl 3): 2325.
  • 12
    Roberts HC, Saeed M, Roberts TP, Brasch RC. Assessment of acute and reperfused myocardial ischemia using GdDTPA, GdDTPA-cascade-24-polymer and albumin-GdDTPA. Acad Radiol 1998; 5(Suppl 1): S31S33. Discussion S45–S46.
  • 13
    Saeed M, van Dijke CF, Mann JS, et al. Histologic confirmation of microvascular hyperpermeability to macromolecular MR contrast medium in reperfused myocardial infarction. J Magn Reson Imaging 1998; 8: 561567.
  • 14
    Brasch RC, Berthezène Y, Vexler V, et al. Pulmonary oxygen toxicity: demonstration of abnormal capillary permeability using contrast-enhanced MRI. Pediatr Radiol 1993; 23: 495500.
  • 15
    White D, Wang S-C, Aicher K, Dupon J, Engelstad B, Brasch R. Albumin-(DTPA-Gd)15-20: whole body clearance, and organ distribution of gadolinium. In: Society of Magnetic Resonance in Medicine, 8th Annual Meeting, Amsterdam, 1989.
  • 16
    Baxter AB, Lazarus SC, Brasch RC. In vitro histamine release induced by magnetic resonance imaging and iodinated contrast media. Invest Radiol 1993; 28: 308312.
  • 17
    Lauffer RB, Parmelee DJ, Dunham SU, et al. MS-325: albumin-targeted contrast agent for MR angiography. Radiology 1998; 207: 529538.
  • 18
    Stoica G, Koestner A. Diverse spectrum of tumors in male Sprague Dawley rats following single high doses of N-ethyl-N-nitrosurea (ENU). Am J Pathol 1984; 116(2): 319326.
  • 19
    Stoica G, Koestner A, Capen C. Neoplasms induced with high single doses of N-ethyl-N-nitrosurea in 30 day-old Sprague Dawley rats, with special emphasis in mammary neoplasia. Anticancer Res 1984; 4: 512.
  • 20
    Schwickert HC, Roberts TP, Shames DM, et al. Quantification of liver blood volume: comparison of ultra short TI inversion recovery echo planar imaging (ULSTIR-EPI), with dynamic 3D-gradient recalled echo imaging. Magn Reson Med 1995; 34: 845852.
  • 21
    Grist TM, Korosec FR, Peters DC, et al. Steady-state and dynamic MR angiography with MS-325: initial experience in humans. Radiology 1998; 207: 539544.
  • 22
    Parmelee DJ, Walovitch RC, Ouellet HS, Lauffer RB. Preclinical evaluation of the pharmacokinetics, biodistribution, and elimination of MS-325, a blood pool agent for magnetic resonance imaging. Invest Radiol 1997; 32: 741747.
  • 23
    Ogan M, Schmiedl U, Moseley M, Grodd W, Paajenen H, Brasch RC. Albumin labeled with Gd-DTPA: an intravascular contrast enhancing agent for magnetic resonance blood pool imaging: preparation and characterization. Invest Radiol 1987; 22: 665671.
  • 24
    Schmiedl U, Ogan M, Moseley M, et al. Comparison of the contrast-enhancing properties of albumin-(Gd-DTPA) and Gd-DTPA at 2.0 T: an experimental study in rats. AJR Am J Roentgenol 1986; 147: 12631270.
  • 25
    Schmiedl U, Brasch RC, Ogan MD, Moseley ME. Albumin labeled with Gd-DTPA An intravascular contrast-enhancing agent for magnetic resonance blood pool and perfusion imaging. Acta Radiol Suppl 1990; 374: 99102.
  • 26
    Shames DM, Kuwatsuru R, Vexler V, Mühler A, Brasch RC. Measurement of capillary permeability to macromolecules by dynamic magnetic resonance imaging: a quantitative noninvasive technique. Magn Reson Med 1993; 29: 616622.
  • 27
    Scarff R, Torloni H. 1968. Histological typing of breast tumors. Geneva: World Health Organization; p 1320.
  • 28
    Bloom H, Richardson W. Histologic grading and prognosis in breast cancer. Br J Cancer 1957; 11: 359377.
  • 29
    Jain RK. Transport of molecules in the tumor interstitium: a review. Cancer Res 1987; 47: 30393051.
  • 30
    Gossmann A, Okuhata Y, Shames DM, et al. Prostate cancer tumor grade differentiation with dynamic contrast-enhanced MR imaging in the rat: comparison of macromolecular and small-molecular contrast media—preliminary experience. Radiology 1999; 213: 265272.
  • 31
    Gossmann A, Helbich T, Mesiano S, et al. Magnetic resonance imaging in ovarian cancer demonstrating altered microvascular permeability following inhibition of vascular endothelial growth factor. Am J Obstet Gyn 2000; 4: 956963.
  • 32
    Prasad PV, Cannillo J, Chavez DR, et al. First-pass renal perfusion imaging using MS-325, an albumin-targeted MRI contrast agent. Invest Radiol 1999; 34: 566571.
  • 33
    Weidner N, Semple JP, Welch WR, Folkman J. Tumor angiogenesis and metastasis—correlation in invasive breast carcinoma. New Engl J Med 1991; 324: 18.